Table of Contents

1 Study Coverage

• 1.1 Neurostimulator Device Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Neurostimulator Device Market Size Growth Rate by Product
  • 1.4.2 Stationary Neurostimulator
  • 1.4.3 Portable Neurostimulator
• 1.5 Market by End User
  • 1.5.1 Global Neurostimulator Device Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Scientific Research
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Neurostimulator Device Market Size
  • 2.1.1 Global Neurostimulator Device Revenue 2014-2025
  • 2.1.2 Global Neurostimulator Device Sales 2014-2025
• 2.2 Neurostimulator Device Growth Rate by Regions
  • 2.2.1 Global Neurostimulator Device Sales by Regions
  • 2.2.2 Global Neurostimulator Device Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Neurostimulator Device Sales by Manufacturers
  • 3.1.1 Neurostimulator Device Sales by Manufacturers
  • 3.1.2 Neurostimulator Device Sales Market Share by Manufacturers
  • 3.1.3 Global Neurostimulator Device Market Concentration Ratio (CR5 and HHI)
• 3.2 Neurostimulator Device Revenue by Manufacturers
  • 3.2.1 Neurostimulator Device Revenue by Manufacturers (2014-2019)
  • 3.2.2 Neurostimulator Device Revenue Share by Manufacturers (2014-2019)
• 3.3 Neurostimulator Device Price by Manufacturers
• 3.4 Neurostimulator Device Manufacturing Base Distribution, Product Types
  • 3.4.1 Neurostimulator Device Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Neurostimulator Device Product Type
  • 3.4.3 Date of International Manufacturers Enter into Neurostimulator Device Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Neurostimulator Device Sales by Product
• 4.2 Global Neurostimulator Device Revenue by Product
• 4.3 Neurostimulator Device Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Neurostimulator Device Breakdown Data by End User

6 North America

• 6.1 North America Neurostimulator Device by Countries
  • 6.1.1 North America Neurostimulator Device Sales by Countries
  • 6.1.2 North America Neurostimulator Device Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Neurostimulator Device by Product
• 6.3 North America Neurostimulator Device by End User

7 Europe

• 7.1 Europe Neurostimulator Device by Countries
  • 7.1.1 Europe Neurostimulator Device Sales by Countries
  • 7.1.2 Europe Neurostimulator Device Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Neurostimulator Device by Product
• 7.3 Europe Neurostimulator Device by End User

8 Asia Pacific

• 8.1 Asia Pacific Neurostimulator Device by Countries
  • 8.1.1 Asia Pacific Neurostimulator Device Sales by Countries
  • 8.1.2 Asia Pacific Neurostimulator Device Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Neurostimulator Device by Product
• 8.3 Asia Pacific Neurostimulator Device by End User

9 Central & South America

• 9.1 Central & South America Neurostimulator Device by Countries
  • 9.1.1 Central & South America Neurostimulator Device Sales by Countries
  • 9.1.2 Central & South America Neurostimulator Device Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Neurostimulator Device by Product
• 9.3 Central & South America Neurostimulator Device by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Neurostimulator Device by Countries
  • 10.1.1 Middle East and Africa Neurostimulator Device Sales by Countries
  • 10.1.2 Middle East and Africa Neurostimulator Device Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Neurostimulator Device by Product
• 10.3 Middle East and Africa Neurostimulator Device by End User

11 Company Profiles

• 11.1 Cyberonics
  • 11.1.1 Cyberonics Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Cyberonics Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Cyberonics Neurostimulator Device Products Offered
  • 11.1.5 Cyberonics Recent Development
• 11.2 Abiomed
  • 11.2.1 Abiomed Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Abiomed Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Abiomed Neurostimulator Device Products Offered
  • 11.2.5 Abiomed Recent Development
• 11.3 MED-EL
  • 11.3.1 MED-EL Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 MED-EL Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 MED-EL Neurostimulator Device Products Offered
  • 11.3.5 MED-EL Recent Development
• 11.4 Philips Healthcare
  • 11.4.1 Philips Healthcare Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Philips Healthcare Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Philips Healthcare Neurostimulator Device Products Offered
  • 11.4.5 Philips Healthcare Recent Development
• 11.5 Cardiac Science
  • 11.5.1 Cardiac Science Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Cardiac Science Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Cardiac Science Neurostimulator Device Products Offered
  • 11.5.5 Cardiac Science Recent Development
• 11.6 Zoll Medical
  • 11.6.1 Zoll Medical Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Zoll Medical Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Zoll Medical Neurostimulator Device Products Offered
  • 11.6.5 Zoll Medical Recent Development
• 11.7 Schiller
  • 11.7.1 Schiller Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Schiller Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Schiller Neurostimulator Device Products Offered
  • 11.7.5 Schiller Recent Development
• 11.8 Nihon Kohden
  • 11.8.1 Nihon Kohden Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Nihon Kohden Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Nihon Kohden Neurostimulator Device Products Offered
  • 11.8.5 Nihon Kohden Recent Development
• 11.9 GE Healthcare
  • 11.9.1 GE Healthcare Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 GE Healthcare Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 GE Healthcare Neurostimulator Device Products Offered
  • 11.9.5 GE Healthcare Recent Development
• 11.10 Cochlear
  • 11.10.1 Cochlear Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Cochlear Neurostimulator Device Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Cochlear Neurostimulator Device Products Offered
  • 11.10.5 Cochlear Recent Development
• 11.11 Boston Scientific
• 11.12 Biotronik
• 11.13 Sorin Group

12 Future Forecast

• 12.1 Neurostimulator Device Market Forecast by Regions
  • 12.1.1 Global Neurostimulator Device Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Neurostimulator Device Revenue Forecast by Regions 2019-2025
• 12.2 Neurostimulator Device Market Forecast by Product
  • 12.2.1 Global Neurostimulator Device Sales Forecast by Product 2019-2025
  • 12.2.2 Global Neurostimulator Device Revenue Forecast by Product 2019-2025
• 12.3 Neurostimulator Device Market Forecast by End User
• 12.4 North America Neurostimulator Device Forecast
• 12.5 Europe Neurostimulator Device Forecast
• 12.6 Asia Pacific Neurostimulator Device Forecast
• 12.7 Central & South America Neurostimulator Device Forecast
• 12.8 Middle East and Africa Neurostimulator Device Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Neurostimulator Device Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Neurostimulator Device market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neurostimulator Device market based on company, product type, end user and key regions.

This report studies the global market size of Neurostimulator Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurostimulator Device in these regions.
This research report categorizes the global Neurostimulator Device market by top players/brands, region, type and end user. This report also studies the global Neurostimulator Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Cyberonics
Abiomed
MED-EL
Philips Healthcare
Cardiac Science
Zoll Medical
Schiller
Nihon Kohden
GE Healthcare
Cochlear
Boston Scientific
Biotronik
Sorin Group

Market size by Product
Stationary Neurostimulator
Portable Neurostimulator
Market size by End User
Hospital
Scientific Research
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Neurostimulator Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Neurostimulator Device market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neurostimulator Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neurostimulator Device submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Neurostimulator Device are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurostimulator Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.